E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/5/2017 in the Prospect News Bank Loan Daily, Prospect News Convertibles Daily and Prospect News Investment Grade Daily.

S&P lowers St. Jude Medical

S&P said it lowered the corporate credit rating on St. Jude Medical Inc. to BBB from A- and maintained the rating on CreditWatch, where it was placed with negative implications in April.

The agency also said it affirmed the A-2 commercial-paper rating.

The downgrades follow the completion of Abbott Laboratories' acquisition of St. Jude for about $25 billion and reflect a view that St. Jude is core to Abbott, S&P said.

The ratings also remain on CreditWatch with negative implications.

S&P said it expects Abbott to exchange St. Jude debt for Abbott debt over the coming weeks, at which point the ratings on St. Jude will be withdrawn.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.